Pfizer Statistics
Total Valuation
Pfizer has a market cap or net worth of $141.82 billion. The enterprise value is $204.37 billion.
Important Dates
The last earnings date was Tuesday, October 29, 2024, before market open.
| Earnings Date | Oct 29, 2024 |
| Ex-Dividend Date | Nov 8, 2024 |
Share Statistics
Pfizer has 5.67 billion shares outstanding. The number of shares has decreased by -0.42% in one year.
| Current Share Class | 5.67B |
| Shares Outstanding | 5.67B |
| Shares Change (YoY) | -0.42% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 68.31% |
| Float | 5.66B |
Valuation Ratios
The trailing PE ratio is 33.62 and the forward PE ratio is 10.20. Pfizer's PEG ratio is 2.02.
| PE Ratio | 33.62 |
| Forward PE | 10.20 |
| PS Ratio | 2.38 |
| Forward PS | 2.21 |
| PB Ratio | 1.53 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 17.18 |
| P/OCF Ratio | 12.55 |
| PEG Ratio | 2.02 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 11.13, with an EV/FCF ratio of 24.84.
| EV / Earnings | 48.06 |
| EV / Sales | 3.44 |
| EV / EBITDA | 11.13 |
| EV / EBIT | 17.78 |
| EV / FCF | 24.84 |
Financial Position
The company has a current ratio of 1.00, with a Debt / Equity ratio of 0.73.
| Current Ratio | 1.00 |
| Quick Ratio | 0.64 |
| Debt / Equity | 0.73 |
| Debt / EBITDA | 3.46 |
| Debt / FCF | 8.26 |
| Interest Coverage | 3.78 |
Financial Efficiency
Return on equity (ROE) is 4.54% and return on invested capital (ROIC) is 4.46%.
| Return on Equity (ROE) | 4.54% |
| Return on Assets (ROA) | 3.31% |
| Return on Capital (ROIC) | 4.46% |
| Revenue Per Employee | $674,716 |
| Profits Per Employee | $48,318 |
| Employee Count | 88,000 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 1.64 |
Taxes
| Income Tax | -402.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.53% in the last 52 weeks. The beta is 0.61, so Pfizer's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | -16.53% |
| 50-Day Moving Average | 28.28 |
| 200-Day Moving Average | 28.11 |
| Relative Strength Index (RSI) | 27.73 |
| Average Volume (20 Days) | 53,560,680 |
Short Selling Information
The latest short interest is 61.87 million, so 1.09% of the outstanding shares have been sold short.
| Short Interest | 61.87M |
| Short Previous Month | 67.62M |
| Short % of Shares Out | 1.09% |
| Short % of Float | 1.09% |
| Short Ratio (days to cover) | 1.83 |
Income Statement
In the last 12 months, Pfizer had revenue of $59.38 billion and earned $4.25 billion in profits. Earnings per share was $0.74.
| Revenue | 59.38B |
| Gross Profit | 41.43B |
| Operating Income | 11.49B |
| Pretax Income | -4.20B |
| Net Income | 4.25B |
| EBITDA | 18.37B |
| EBIT | 11.49B |
| Earnings Per Share (EPS) | $0.74 |
Full Income StatementBalance Sheet
The company has $9.95 billion in cash and $67.95 billion in debt, giving a net cash position of -$57.99 billion or -$10.23 per share.
| Cash & Cash Equivalents | 9.95B |
| Total Debt | 67.95B |
| Net Cash | -57.99B |
| Net Cash Per Share | -$10.23 |
| Equity (Book Value) | 92.56B |
| Book Value Per Share | 16.29 |
| Working Capital | 12.00M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $11.26 billion and capital expenditures -$3.04 billion, giving a free cash flow of $8.23 billion.
| Operating Cash Flow | 11.26B |
| Capital Expenditures | -3.04B |
| Free Cash Flow | 8.23B |
| FCF Per Share | $1.45 |
Full Cash Flow StatementMargins
Gross margin is 69.78%, with operating and profit margins of 19.36% and 7.16%.
| Gross Margin | 69.78% |
| Operating Margin | 19.36% |
| Pretax Margin | 6.58% |
| Profit Margin | 7.16% |
| EBITDA Margin | 30.93% |
| EBIT Margin | 19.36% |
| FCF Margin | 8.64% |
Dividends & Yields
This stock pays an annual dividend of $1.68, which amounts to a dividend yield of 6.71%.
| Dividend Per Share | $1.68 |
| Dividend Yield | 6.71% |
| Dividend Growth (YoY) | 2.44% |
| Years of Dividend Growth | 13 |
| Payout Ratio | 225.68% |
| Buyback Yield | 0.42% |
| Shareholder Yield | 7.16% |
| Earnings Yield | 3.01% |
| FCF Yield | 5.82% |
Dividend DetailsAnalyst Forecast
The average price target for Pfizer is $33.17, which is 32.55% higher than the current price. The consensus rating is "Buy".
| Price Target | $33.17 |
| Price Target Difference | 32.55% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 1.48% |
| EPS Growth Forecast (5Y) | 50.93% |
Stock ForecastsStock Splits
The last stock split was on July 1, 1999. It was a forward split with a ratio of 3:1.
| Last Split Date | Jul 1, 1999 |
| Split Type | Forward |
| Split Ratio | 3:1 |
Scores
Pfizer has an Altman Z-Score of 1.98 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.98 |
| Piotroski F-Score | 6 |